BK

Balasubramanian Keerthivisagan

Active Director Director DIN 11565528
DIN 11565528 First appointment Feb 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Balasubramanian Keerthivisagan

Data last updated:

Balasubramanian Keerthivisagan is a Director at Keerthi Hospitals Private Limited (since 2026). The company operates in Healthcare.

DIN 11565528
Primary Designation Director
Industry Healthcare
First Appointment 23 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Keerthi Hospitals Private Limited U86100TN2026PTC190013
Director23 Feb 20262026Active

Board colleagues of Balasubramanian Keerthivisagan

Directorship timeline

Open interactive timeline →
Keerthi Hospitals Private Limited
Premium access

Shareholding and investment profile for Balasubramanian Keerthivisagan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balasubramanian Keerthivisagan

Balasubramanian Keerthivisagan currently holds 1 directorship: Keerthi Hospitals Private Limited (Director, since 23 Feb 2026).

Balasubramanian Keerthivisagan was first appointed on 23 Feb 2026 as Director at Keerthi Hospitals Private Limited.

The current boards of Balasubramanian Keerthivisagan's companies include Balasubramanian Akila (Keerthi Hospitals Private Limited), Balasubramanian Mahaswetha (Keerthi Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available